Mold and other fungi can grow inside the human body, though it happens far less often than people might fear after seeing a scary headline. Your body temperature and immune system form a remarkably effective double barrier that keeps the vast majority of fungal species from gaining a foothold. Of the millions of fungal species estimated to exist, only a few hundred cause disease in humans. When fungi do establish themselves internally, the infections range from mild surface colonization of airways to life-threatening invasive disease, and the people most vulnerable are almost always those whose defenses have been compromised in some specific, identifiable way.
Why Your Body Is Hostile Territory for Most Fungi
Fungi, as a rule, prefer cooler environments. Most species thrive at temperatures well below the roughly 37°C (98.6°F) that mammals maintain, and their ability to grow drops off sharply as temperatures climb. This thermal mismatch is not an accident of evolution. Researchers have argued that the warm-blooded body temperature of mammals functions as a thermal exclusion zone, making the internal environment inhospitable to the overwhelming majority of fungal species on the planet.1PubMed. Fungal virulence, vertebrate endothermy, and dinosaur extinction: is there a connection? Modeling work has shown that fungal species lose their capacity for growth rapidly above ambient temperatures, and that the relatively few species capable of surviving at mammalian body heat are the ones we see causing human infections.2PubMed Central. Mammalian endothermy optimally restricts fungi and metabolic costs
On top of the thermal barrier sits the immune system. White blood cells, particularly neutrophils and macrophages, actively patrol tissues for fungal invaders and destroy them. The combination of body heat plus active immune surveillance is what makes invasive fungal disease so rare in otherwise healthy people.3PubMed Central. Global warming will bring new fungal diseases for mammals When one or both of those barriers weakens, the odds shift dramatically.
How Fungi Actually Establish Themselves Inside You
When fungi do get past the body’s defenses, the route of entry matters. Most lung-related fungal infections start with inhaling spores, which are everywhere in outdoor air and in many indoor environments. Healthy lungs clear these spores without incident. But in people with damaged lungs, weakened immune systems, or both, the spores can germinate and begin growing as thread-like structures called hyphae that invade living tissue.
Candida, the yeast behind common thrush and vaginal yeast infections, takes a different approach. It already lives on your skin and in your gut as a normal part of your body’s microbial community. Problems arise when something disrupts that balance, like a course of antibiotics wiping out competing bacteria, or a disease state suppressing immune function. In its disease-causing mode, Candida switches from a round yeast form to an elongated hyphal form that can physically penetrate mucosal tissue and, in severe cases, enter the bloodstream.4PubMed Central. The regulation of hyphae growth in Candida albicans That shape-shifting ability is central to how it causes harm.
A third route is direct inoculation. Fungal keratitis, an infection of the cornea, often follows eye trauma involving plant material, soil, or contaminated contact lenses. Aspergillus and Fusarium species are the most common culprits, and a history of physical injury to the eye is a major predisposing factor.5PubMed. Fungal keratitis: A review of clinical presentations, treatment strategies and outcomes Similar inoculation can happen through deep wounds contaminated with soil, particularly in natural disasters or combat settings where wound care is delayed.
The Fungus Ball in the Lung
One of the more striking examples of mold growing inside the body is an aspergilloma, sometimes called a fungus ball. This is a rounded mass of fungal filaments, mucus, and debris that forms inside an existing cavity in the lung. People develop lung cavities for various reasons: previous tuberculosis, sarcoidosis, emphysema, or other conditions that leave empty spaces in lung tissue. Aspergillus spores settle into these cavities and, rather than invading the surrounding tissue, grow into a dense tangle that can be seen clearly on a chest X-ray.6PubMed. Non-surgical treatment options for pulmonary aspergilloma
Aspergillomas are the most common way Aspergillus species affect the lungs. Many people with a small fungus ball have no symptoms at all and discover it incidentally on imaging done for another reason. The main risk is bleeding: the mass can erode into small blood vessels lining the cavity wall, causing coughing up blood that ranges from minor streaking to severe hemorrhage.7BMJ Case Reports. Behind the fungus ball: pulmonary aspergillosis! The fungus is not invading healthy tissue in the classic aspergilloma; it is colonizing dead space. That distinction matters because treatment decisions depend heavily on whether the fungus is just sitting in a cavity or actively spreading into surrounding tissue.
When the Immune System Is the Weak Link
The most dangerous fungal infections happen when the immune system cannot do its job. The list of conditions that create this vulnerability is long and keeps growing as modern medicine finds new ways to suppress the immune system for therapeutic purposes. Cancer chemotherapy, organ transplantation requiring anti-rejection drugs, HIV/AIDS, and prolonged courses of corticosteroids are all well-established risk factors. More recently, newer biologic therapies, including monoclonal antibodies and small-molecule drugs used for autoimmune diseases and certain cancers, have been linked to fungal infections as an under-recognized complication.8PubMed. Invasive Fungal Infections as a Complication of New Therapies
Mucormycosis illustrates the stakes well. Caused by molds in the Mucorales order, it typically strikes people whose immune defenses are severely compromised. Patients with diabetic ketoacidosis, a dangerous complication of diabetes, are particularly susceptible. The fungus aggressively invades blood vessels, cutting off blood supply to surrounding tissue and causing rapid tissue death. Without early diagnosis and treatment, the infection progresses to fatal outcomes.9PubMed. Diabetic ketoacidosis and rhino-orbital mucormycosis It most commonly begins in the sinuses and can spread to the eye socket and brain. The speed at which mucormycosis progresses, and the disfiguring surgery often needed to control it, make it one of the most feared fungal infections in medicine.
Allergic Responses Versus Actual Infection
Not every problem mold causes inside the body involves the fungus actively growing in tissue. Allergic bronchopulmonary aspergillosis, known as ABPA, is a condition where Aspergillus colonizes the airways of people with asthma or cystic fibrosis, and the immune system overreacts to its presence. The damage comes not from the fungus invading tissue but from the inflammatory response the body mounts against it.10PubMed Central. Allergic bronchopulmonary aspergillosis Symptoms include worsening asthma, recurrent mucus plugging, and eventually permanent airway damage if untreated.
This distinction between colonization-plus-allergy and true tissue invasion shows up in the sinuses as well. Fungal sinusitis comes in both invasive and noninvasive forms. The noninvasive version can involve a fungus ball in a sinus cavity (similar to the lung aspergilloma) or an allergic response to fungal material in the sinuses, neither of which involves the fungus actually penetrating tissue. The invasive form, by contrast, involves fungal hyphae growing through the sinus lining into bone, blood vessels, and potentially the brain. It is classified based on whether there is histologic evidence of the fungus actually invading tissue.11Neuroimaging Clinics of North America. Imaging Features of Invasive and Noninvasive Fungal Sinusitis Whether your doctor treats you with allergy medications, antifungals, or emergency surgery depends entirely on which category you fall into.
Medical Devices and Fungal Biofilms
Modern medicine introduces foreign materials into the body constantly: catheters, prosthetic heart valves, joint replacements, pacemaker leads, voice prostheses. These surfaces give fungi, particularly Candida species, something to grip onto. Candida albicans and several related species can form biofilms on virtually any implanted biomaterial.12PubMed. The effect of biomaterials and antifungals on biofilm formation by Candida species: a review A biofilm is a structured community of organisms encased in a self-produced matrix, and it is dramatically harder to treat than free-floating organisms in the blood.
The process has been studied in detail. Candida cells first attach to the device surface, then organize into complex multilayered communities protected by a polysaccharide shell.13PubMed. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance Once a mature biofilm forms, antifungal drugs penetrate it poorly. That is why a catheter-related fungal bloodstream infection often cannot be cured without physically removing the contaminated device. Fungal biofilms on medical devices have become a significant cause of illness and death in hospitalized and immunocompromised patients.14PubMed Central. Fungal Biofilms: Relevance in the Setting of Human Disease
The COVID-19 Connection
The COVID-19 pandemic brought fungal superinfections into public awareness in a way nothing else had. Waves of mucormycosis cases in India made global headlines, and pulmonary aspergillosis in critically ill COVID patients became a recognized complication worldwide. The reasons were layered. Severe COVID-19 itself damages the lung lining, disrupting the physical barriers that normally keep inhaled spores from gaining a foothold. On top of that, the heavy use of corticosteroids and other immune-modulating treatments to manage the inflammatory storm of severe COVID further suppressed the very immune responses needed to clear fungi.15PubMed Central. COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis
This was not entirely new. Influenza has long been recognized as a risk factor for invasive pulmonary aspergillosis, and severe viral lung infections in general have emerged as a recognized gateway to fungal disease. The pattern across both influenza and COVID-19 is consistent: viral destruction of lung tissue plus immune suppression, whether from the virus itself or from the treatments used against it, creates the conditions fungi need to invade.16PubMed Central. Pathogenesis of Respiratory Viral and Fungal Coinfections
How Internal Fungal Infections Are Diagnosed
Diagnosing mold growing inside the body is harder than most people would assume. The gold standard is taking a tissue sample and showing, under the microscope, that fungal hyphae are actually invading tissue, or growing mold from a sample collected under sterile conditions. But biopsies are invasive, and many of the patients at highest risk for fungal infections are too sick, or have too few platelets for safe clotting, to undergo them.17PubMed Central. Diagnosis and Treatment of Invasive Mold Diseases
Blood cultures, the workhorse of bacterial infection diagnosis, are nearly useless for molds. Most molds simply do not grow well in blood culture bottles. Instead, clinicians rely on indirect markers. One is galactomannan, a sugar molecule found in the cell wall of Aspergillus species, which can be detected in blood or lung fluid. Another is beta-D-glucan, a broader fungal cell wall component detected by an assay that exploits the clotting mechanism of horseshoe crab blood. Both tests can flag a likely fungal infection days before a culture would turn positive, which matters enormously when the infection can progress from treatable to fatal within that same window.18Journal of Antimicrobial Chemotherapy. Early diagnosis of invasive mould infections and disease CT imaging also plays a key role: certain patterns, like a dense nodule surrounded by a halo of ground-glass opacity, are highly suggestive of invasive mold disease in the right clinical context.
Antifungal Resistance and Agricultural Fungicides
Treating fungal infections that have taken hold inside the body relies on a relatively small arsenal of antifungal drugs, and resistance is a growing concern. Triazole antifungals are a cornerstone of treating Aspergillus infections. But triazoles are also widely used as agricultural fungicides to protect crops, and this dual use has created an unexpected problem. Aspergillus fumigatus strains found causing disease in humans have been linked to resistance patterns that match agricultural fungicide exposure, suggesting that mold evolving in farm fields can later infect a person’s lungs and resist the same class of drug doctors would use to treat the infection.19PubMed Central. Trends in Agricultural Triazole Fungicide Use in the United States, 1992-2016 and Possible Implications for Antifungal-Resistant Fungi in Human Disease
This is a genuinely worrying dynamic. Unlike antibacterial resistance, where most selective pressure comes from clinical antibiotic use, antifungal resistance can develop in the environment, far from any hospital, and then show up in a patient who has never taken an antifungal drug. The pipeline of new antifungal agents has historically been thin compared with antibacterials, so losing the effectiveness of existing drugs carries outsized consequences.
Climate Change and the Expanding Threat
The thermal barrier that protects mammals from most fungi may be eroding. As average environmental temperatures rise, fungi are being subjected to sustained selective pressure to tolerate higher heat. The concern is that species previously unable to survive at human body temperature could gradually adapt to warmer conditions, potentially crossing the threshold into human pathogenicity.20The Lancet Infectious Diseases. Climate change, natural disasters, and fungal infections
Candida auris, a multidrug-resistant yeast that emerged seemingly out of nowhere on three continents simultaneously around 2009, has been proposed as a possible early example of this phenomenon. It tolerates higher temperatures than most of its close relatives and spreads easily in healthcare settings. Whether climate change specifically drove its emergence remains debated, but the broader principle is well-supported: rising environmental temperatures could shrink the thermal gap between the outside world and our body’s internal temperature, potentially expanding the roster of fungi capable of infecting us.3PubMed Central. Global warming will bring new fungal diseases for mammals Researchers have characterized this as a slow erosion of the thermal defense that has protected mammals for tens of millions of years.
Who Should Actually Worry
If you are a healthy adult with no chronic lung disease, no immune-suppressing conditions, and no implanted medical devices, the risk of mold growing inside your body is extremely low. Your temperature and immune system handle the constant background exposure to airborne spores without you ever noticing. Living in a moldy house is unpleasant, can trigger allergic symptoms and asthma flares, and should be remediated, but it is not going to cause mold to colonize your organs.
The people who do need to worry fall into identifiable groups:
- Immunosuppressed patients: organ transplant recipients, people on chemotherapy, those taking long-term corticosteroids or newer biologic drugs, and people with uncontrolled HIV.
- People with lung cavities: prior TB, severe emphysema, sarcoidosis, or other structural lung disease can provide the physical space fungi need to grow.
- Hospitalized patients with devices: central venous catheters, urinary catheters, and prosthetic materials offer surfaces for fungal biofilms to develop.
- Poorly controlled diabetics: diabetic ketoacidosis in particular changes the body’s internal chemistry in ways that favor mucormycosis.
- People recovering from severe viral pneumonia: the combination of damaged lung tissue and treatment-related immune suppression creates a window of vulnerability.
For people in these groups, awareness matters practically. Persistent fever that does not respond to antibiotics, new or worsening respiratory symptoms during immunosuppression, or sinus pain with dark nasal discharge in a diabetic patient are all red flags that should prompt consideration of a fungal cause. Early treatment is consistently the factor that separates survivable invasive fungal infections from fatal ones.